Table 2.

Dietary supplements with artichoke used in selected countries, based on European Medicines Agency [115] and by Mahboubi [107].

Country	Dietary Supplement	Diseases	Advance Effect
Austria	1–2 coated tables or capsules (350 mg), three times daily	Digestive complaints, dyspepsia	No advance effect known
Belgium	Three coated tables or capsules (200 mg), two times daily	Digestive complaints, dyspepsia	No advance effect known
Bulgaria	1–2 coated tablets, three times daily, or 1–2 teaspoon of solution, three times daily	Dyspepsia, and enhancing the fatty acid metabolism	Hypersensibility, diarrhea, nausea, flatulence
France	1–2 coated tablets (200 mg), three times daily, or 1 ampule (10 mL), three times daily	Digestive and urinary complaints, dyspepsia	No advance effect known
Germany	One coated tablet (300 mg), 1–2 times daily	Digestive complaints, dyspepsia	Slight diarrhea, epigastric complaints
Poland	Two tablets, one a day (digestive disorders) or 2 tablets, three times daily (hyperlipidaemia)	Digestive complaints and hepatobiliary disturbances, mild to moderate hyperlipidemia	Mild gastro-intestinal disturbances
Spain	600–1500 mg a day–capsules	Dyspepsia	No advance effect known
United Kingdom	one capsule, twice daily	Digestive complaints	No advance effect known